Switching stable kidney transplant recipients to a generic tacrolimus Is feasible and safe, but it must be monitored
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi Publishing Corp.
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
5
item.page.accessRights
item.page.other
item.page.references
Abstract
Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Mi...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
González F, López R, Arriagada E, Carrasco R, Gallardo N, Lorca E. Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored. J Transplant. 2017;2017:5646858. doi: 10.1155/2017/5646858.
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026